Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Setting relevant patient differences--a problem in phase-IV research.

I M Blackburn

    Pharmacopsychiatry
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Moderators of trainee therapists' competence in cognitive therapy.

    The British journal of clinical psychology·2001
    Same author

    Effectiveness of cognitive therapy training.

    Journal of behavior therapy and experimental psychiatry·1999
    Same author

    Co-morbid depression and drinking outcome in those with alcohol dependence.

    Alcohol and alcoholism (Oxford, Oxfordshire)·1998
    Same author

    A meta-analysis of the effects of cognitive therapy in depressed patients.

    Journal of affective disorders·1998
    Same author

    Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression.

    The British journal of psychiatry : the journal of mental science·1997
    Same author

    Cognitive therapy with obsessive-compulsive disorder.

    The British journal of psychiatry : the journal of mental science·1995
    Same journal

    A Tribute to Prof. Jules Angst highlighting his Contributions to Clozapine.

    Pharmacopsychiatry·2026
    Same journal

    Correction: Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain.

    Pharmacopsychiatry·2026
    Same journal

    Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

    Pharmacopsychiatry·2026
    Same journal

    Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

    Pharmacopsychiatry·2026
    Same journal

    Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.

    Pharmacopsychiatry·2026
    Same journal

    A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis.

    Pharmacopsychiatry·2026
    See all related articles

    Treatment outcomes for major depressive disorder differ based on care setting, even with identical treatments. Healthcare providers must evaluate treatment effectiveness within specific clinical environments, as general recommendations are not universally applicable.

    Area of Science:

    • Clinical Psychology
    • Psychiatry
    • Health Services Research

    Background:

    • Major depressive disorder (MDD) is a prevalent mental health condition.
    • Treatment effectiveness can be influenced by various patient and setting-specific factors.
    • Existing research often overlooks variations in treatment outcomes across different healthcare settings.

    Purpose of the Study:

    • To compare treatment outcomes for primary major depressive disorder in hospital outpatient clinics versus general practices.
    • To identify differences in patient characteristics and illness trajectories between the two settings.
    • To determine if identical treatment procedures yield different outcomes depending on the clinical setting.

    Main Methods:

    • A treatment outcome study involving patients diagnosed with primary major depressive disorder (MDD).

    Related Experiment Videos

  • Inclusion criteria mandated RDC criteria for MDD and a Beck Depression Inventory score of ≥14.
  • Patients were recruited from both a hospital outpatient clinic and a general practice setting.

    • Main Results:

    • Despite identical inclusion criteria and treatment protocols, significant differences were observed in sociodemographic variables, psychopathology, and illness course between GP and hospital patients.
    • Crucially, treatment outcomes varied significantly between the two settings.
    • These variations occurred despite the use of identical treatment procedures.

    Conclusions:

    • Treatment recommendations for major depressive disorder require evaluation within the specific clinical setting where they are to be applied.
    • Generalizing treatment findings from one healthcare setting (e.g., hospital outpatient) to another (e.g., general practice) is not scientifically valid.
    • Clinical practice guidelines should consider setting-specific data for optimal patient care in depression.